MedTrace Logo

Study of a Novel Interposition Supraciliary Implant in Patients With Open Angle Glaucoma

NCT03736655 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2021-12-20

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and effectiveness of a novel interposition supraciliary implant as a stand-alone therapy for lowering intraocular pressure (IOP) in patients with primary open angle glaucoma (POAG) who have failed at least one class of topical medical therapy

Conditions

  • Glaucoma, Open-Angle

Interventions

DEVICE

Interposition supraciliary implant

Surgical placement of an interposition supraciliary implant in the supraciliary space

Sponsors & Collaborators

  • Ciliatech

    lead INDUSTRY

Principal Investigators

  • Philippe SOURDILLE · Ciliatech

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-15
Primary Completion
2021-04-01
Completion
2021-10-25

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03736655 on ClinicalTrials.gov